172 related articles for article (PubMed ID: 22581438)
1. Role of ROS/RhoA/PI3K/PKB signaling in NS1619-mediated blood-tumor barrier permeability increase.
Gu YT; Xue YX; Wang YF; Wang JH; ShangGuan QR; Zhang JX; Qin LJ
J Mol Neurosci; 2012 Sep; 48(1):302-12. PubMed ID: 22581438
[TBL] [Abstract][Full Text] [Related]
2. Minoxidil sulfate induced the increase in blood-brain tumor barrier permeability through ROS/RhoA/PI3K/PKB signaling pathway.
Gu YT; Xue YX; Wang YF; Wang JH; Chen X; ShangGuan QR; Lian Y; Zhong L; Meng YN
Neuropharmacology; 2013 Dec; 75():407-15. PubMed ID: 23973310
[TBL] [Abstract][Full Text] [Related]
3. Role of RhoA/ROCK signaling in endothelial-monocyte-activating polypeptide II opening of the blood-tumor barrier: role of RhoA/ROCK signaling in EMAP II opening of the BTB.
Xie H; Xue YX; Liu LB; Liu YH; Wang P
J Mol Neurosci; 2012 Mar; 46(3):666-76. PubMed ID: 21647708
[TBL] [Abstract][Full Text] [Related]
4. Calcium-activated potassium channel activator down-regulated the expression of tight junction protein in brain tumor model in rats.
Gu YT; Xue YX; Wei XY; Zhang H; Li Y
Neurosci Lett; 2011 Apr; 493(3):140-4. PubMed ID: 21334421
[TBL] [Abstract][Full Text] [Related]
5. NS1619 regulates the expression of caveolin-1 protein in a time-dependent manner via ROS/PI3K/PKB/FoxO1 signaling pathway in brain tumor microvascular endothelial cells.
Cai RP; Xue YX; Huang J; Wang JH; Wang JH; Zhao SY; Guan TT; Zhang Z; Gu YT
J Neurol Sci; 2016 Oct; 369():109-118. PubMed ID: 27653874
[TBL] [Abstract][Full Text] [Related]
6. Signal mechanisms underlying low-dose endothelial monocyte-activating polypeptide-II-induced opening of the blood-tumor barrier.
Li Z; Liu YH; Xue YX; Liu LB; Wang P
J Mol Neurosci; 2012 Sep; 48(1):291-301. PubMed ID: 22531886
[TBL] [Abstract][Full Text] [Related]
7. Low-Dose Endothelial Monocyte-Activating Polypeptide-II Increases Blood-Tumor Barrier Permeability by Activating the RhoA/ROCK/PI3K Signaling Pathway.
Li Z; Liu XB; Liu YH; Xue YX; Liu J; Teng H; Xi Z; Yao YL
J Mol Neurosci; 2016 Jun; 59(2):193-202. PubMed ID: 26521255
[TBL] [Abstract][Full Text] [Related]
8. RhoA-mediated potential regulation of blood-tumor barrier permeability by bradykinin.
Ma T; Xue Y
J Mol Neurosci; 2010 Sep; 42(1):67-73. PubMed ID: 20369389
[TBL] [Abstract][Full Text] [Related]
9. RhoA/ROCK-2 Pathway Inhibition and Tight Junction Protein Upregulation by Catalpol Suppresses Lipopolysaccaride-Induced Disruption of Blood-Brain Barrier Permeability.
Feng S; Zou L; Wang H; He R; Liu K; Zhu H
Molecules; 2018 Sep; 23(9):. PubMed ID: 30227623
[TBL] [Abstract][Full Text] [Related]
10. miR-132-3p boosts caveolae-mediated transcellular transport in glioma endothelial cells by targeting PTEN/PI3K/PKB/Src/Cav-1 signaling pathway.
Gu Y; Cai R; Zhang C; Xue Y; Pan Y; Wang J; Zhang Z
FASEB J; 2019 Jan; 33(1):441-454. PubMed ID: 30024792
[TBL] [Abstract][Full Text] [Related]
11. Bradykinin increases blood-tumor barrier permeability by down-regulating the expression levels of ZO-1, occludin, and claudin-5 and rearranging actin cytoskeleton.
Liu LB; Xue YX; Liu YH; Wang YB
J Neurosci Res; 2008 Apr; 86(5):1153-68. PubMed ID: 18183615
[TBL] [Abstract][Full Text] [Related]
12. Borneol increases blood-tumour barrier permeability by regulating the expression levels of tight junction-associated proteins.
Duan M; Xing Y; Guo J; Chen H; Zhang R
Pharm Biol; 2016 Dec; 54(12):3009-3018. PubMed ID: 27431008
[TBL] [Abstract][Full Text] [Related]
13. Reactive oxygen species alter brain endothelial tight junction dynamics via RhoA, PI3 kinase, and PKB signaling.
Schreibelt G; Kooij G; Reijerkerk A; van Doorn R; Gringhuis SI; van der Pol S; Weksler BB; Romero IA; Couraud PO; Piontek J; Blasig IE; Dijkstra CD; Ronken E; de Vries HE
FASEB J; 2007 Nov; 21(13):3666-76. PubMed ID: 17586731
[TBL] [Abstract][Full Text] [Related]
14. Krüppel-like factor 4 regulates blood-tumor barrier permeability via ZO-1, occludin and claudin-5.
Ma J; Wang P; Liu Y; Zhao L; Li Z; Xue Y
J Cell Physiol; 2014 Jul; 229(7):916-26. PubMed ID: 24318462
[TBL] [Abstract][Full Text] [Related]
15. Adenosine 5'-triphosphate-sensitive potassium channel-mediated blood-brain tumor barrier permeability increase in a rat brain tumor model.
Ningaraj NS; Rao MK; Black KL
Cancer Res; 2003 Dec; 63(24):8899-911. PubMed ID: 14695207
[TBL] [Abstract][Full Text] [Related]
16. Roundabout 4 regulates blood-tumor barrier permeability through the modulation of ZO-1, Occludin, and Claudin-5 expression.
Cai H; Liu W; Xue Y; Shang X; Liu J; Li Z; Wang P; Liu L; Hu Y; Liu Y
J Neuropathol Exp Neurol; 2015 Jan; 74(1):25-37. PubMed ID: 25470344
[TBL] [Abstract][Full Text] [Related]
17. Methamphetamine reduces expressions of tight junction proteins, rearranges F-actin cytoskeleton and increases the blood brain barrier permeability via the RhoA/ROCK-dependent pathway.
Xue Y; He JT; Zhang KK; Chen LJ; Wang Q; Xie XL
Biochem Biophys Res Commun; 2019 Feb; 509(2):395-401. PubMed ID: 30594393
[TBL] [Abstract][Full Text] [Related]
18. KHDRBS3 regulates the permeability of blood-tumor barrier via cDENND4C/miR-577 axis.
Wu P; Gao Y; Shen S; Xue Y; Liu X; Ruan X; Shao L; Liu Y; Wang P
Cell Death Dis; 2019 Jul; 10(7):536. PubMed ID: 31296839
[TBL] [Abstract][Full Text] [Related]
19. Evidence for involvement of ROCK signaling in bradykinin-induced increase in murine blood-tumor barrier permeability.
Ma T; Liu L; Wang P; Xue Y
J Neurooncol; 2012 Jan; 106(2):291-301. PubMed ID: 21892742
[TBL] [Abstract][Full Text] [Related]
20. The role of histamine in opening blood-tumor barrier.
Wang Z; Cai XJ; Qin J; Xie FJ; Han N; Lu HY
Oncotarget; 2016 May; 7(21):31299-310. PubMed ID: 27121317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
